Is survivin the potential achilles' heel of cancer?

Alvaro Lladser, Carlos Sanhueza, Rolf Kiessling, Andrew F G Quest

Resultado de la investigación: Article

38 Citas (Scopus)

Resumen

Survivin, the smallest member of the inhibitors of apoptosis proteins (IAPs), plays an important role in the control of apoptosis, cell division, and cell migration/metastasis. Survivin is expressed and required for normal fetal development but is then generally no longer present in most adult tissues. However, reexpression of survivin is observed in numerous human cancers where presence of the protein is associated with enhanced proliferation, metastasis, poor prognosis, and decreased patient survival. Given the relatively selective expression in cancer cells, but not in normal tissue (tumor-associated antigen), and its importance in tumor cell biology, survivin has emerged as an attractive target for cancer treatment. Here, we discuss some aspects of survivin biology by focusing on why the protein appears to be so important for cancer cells and then discuss strategies that harness this dependence to eradicate tumors and situate survivin as a potential Achilles' heel of cancer.

Idioma originalEnglish
Páginas (desde-hasta)1-37
Número de páginas37
PublicaciónAdvances in Cancer Research
Volumen111
DOI
EstadoPublished - 1 ene 2011

Huella dactilar

Neoplasms
Inhibitor of Apoptosis Proteins
Neoplasm Metastasis
Neoplasm Antigens
Fetal Development
Cell Division
Cell Movement
Cell Biology
Proteins
Apoptosis
Survival
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Citar esto

Lladser, Alvaro ; Sanhueza, Carlos ; Kiessling, Rolf ; Quest, Andrew F G. / Is survivin the potential achilles' heel of cancer?. En: Advances in Cancer Research. 2011 ; Vol. 111. pp. 1-37.
@article{1d942652c6a448d9bace52d142a2d9fe,
title = "Is survivin the potential achilles' heel of cancer?",
abstract = "Survivin, the smallest member of the inhibitors of apoptosis proteins (IAPs), plays an important role in the control of apoptosis, cell division, and cell migration/metastasis. Survivin is expressed and required for normal fetal development but is then generally no longer present in most adult tissues. However, reexpression of survivin is observed in numerous human cancers where presence of the protein is associated with enhanced proliferation, metastasis, poor prognosis, and decreased patient survival. Given the relatively selective expression in cancer cells, but not in normal tissue (tumor-associated antigen), and its importance in tumor cell biology, survivin has emerged as an attractive target for cancer treatment. Here, we discuss some aspects of survivin biology by focusing on why the protein appears to be so important for cancer cells and then discuss strategies that harness this dependence to eradicate tumors and situate survivin as a potential Achilles' heel of cancer.",
keywords = "Apoptosis, Autoimmunity, Cancer therapy, Gene transfer, Oncogenic potential, Survivin",
author = "Alvaro Lladser and Carlos Sanhueza and Rolf Kiessling and Quest, {Andrew F G}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-385524-4.00001-5",
language = "English",
volume = "111",
pages = "1--37",
journal = "Advances in Cancer Research",
issn = "0065-230X",
publisher = "Academic Press Inc.",

}

Is survivin the potential achilles' heel of cancer? / Lladser, Alvaro; Sanhueza, Carlos; Kiessling, Rolf; Quest, Andrew F G.

En: Advances in Cancer Research, Vol. 111, 01.01.2011, p. 1-37.

Resultado de la investigación: Article

TY - JOUR

T1 - Is survivin the potential achilles' heel of cancer?

AU - Lladser, Alvaro

AU - Sanhueza, Carlos

AU - Kiessling, Rolf

AU - Quest, Andrew F G

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Survivin, the smallest member of the inhibitors of apoptosis proteins (IAPs), plays an important role in the control of apoptosis, cell division, and cell migration/metastasis. Survivin is expressed and required for normal fetal development but is then generally no longer present in most adult tissues. However, reexpression of survivin is observed in numerous human cancers where presence of the protein is associated with enhanced proliferation, metastasis, poor prognosis, and decreased patient survival. Given the relatively selective expression in cancer cells, but not in normal tissue (tumor-associated antigen), and its importance in tumor cell biology, survivin has emerged as an attractive target for cancer treatment. Here, we discuss some aspects of survivin biology by focusing on why the protein appears to be so important for cancer cells and then discuss strategies that harness this dependence to eradicate tumors and situate survivin as a potential Achilles' heel of cancer.

AB - Survivin, the smallest member of the inhibitors of apoptosis proteins (IAPs), plays an important role in the control of apoptosis, cell division, and cell migration/metastasis. Survivin is expressed and required for normal fetal development but is then generally no longer present in most adult tissues. However, reexpression of survivin is observed in numerous human cancers where presence of the protein is associated with enhanced proliferation, metastasis, poor prognosis, and decreased patient survival. Given the relatively selective expression in cancer cells, but not in normal tissue (tumor-associated antigen), and its importance in tumor cell biology, survivin has emerged as an attractive target for cancer treatment. Here, we discuss some aspects of survivin biology by focusing on why the protein appears to be so important for cancer cells and then discuss strategies that harness this dependence to eradicate tumors and situate survivin as a potential Achilles' heel of cancer.

KW - Apoptosis

KW - Autoimmunity

KW - Cancer therapy

KW - Gene transfer

KW - Oncogenic potential

KW - Survivin

UR - http://www.scopus.com/inward/record.url?scp=79959500292&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-385524-4.00001-5

DO - 10.1016/B978-0-12-385524-4.00001-5

M3 - Article

C2 - 21704829

AN - SCOPUS:79959500292

VL - 111

SP - 1

EP - 37

JO - Advances in Cancer Research

JF - Advances in Cancer Research

SN - 0065-230X

ER -